Summary
Background:
Since the start of the European Society of Phenylketonuria and Allied Disorders Treated as Phenylketonuria (ESPKU) in 1987, an increasing number of parental organizations of member countries have joined. Treatment varies widely within Europe. A survey among professionals was done to determine goals and practice.
Method:
In 2005, a questionnaire was sent to professionals of member countries, addressing diagnostic and treatment procedures, numbers of patients necessary for a PKU centre, guidelines followed, numbers of patients treated and professionals involved in care, target phenylalanine concentrations, amount of protein prescribed, frequency of monitoring and clinical visits, need for follow-up of various clinical and biochemical data, the importance of various abnormalities, and definition of (non)compliance.
Results:
Seventeen centres of 12 countries answered. Professionals of 13 countries could not be reached or did not respond. Differences in care were observed in many issues of care including target phenylalanine concentrations. Only few issues had general consensus.
Conclusion:
Not all countries were really active at ESPKU level. In the active countries, a professional could not always be contacted. Responses show that PKU care varies largely between European countries. Notwithstanding the large diversity on many issues of day-to-day care and therapeutic targets, results showed increasing consensus on some issues. The most important outcome of this questionnaire might be that the Scientific Advisory Committee of the ESPKU initiated meetings for professionals of different backgrounds taking care of PKU patients besides the already existing programme for parents, patients and delegates. Discussion among these professionals may improve quality of care.
Similar content being viewed by others
Abbreviations
- ESPKU:
-
European Society of Phenylketonuria and Allied Disorders Treated as Phenylketonuria
- MRI:
-
magnetic resonance imaging
- MRS:
-
magnetic resonance spectroscopy
- Phe:
-
phenylalanine
- PKU:
-
phenylketonuria
References
Burgard P, Rey F, Rupp A, Abadie V, Rey J (1997) Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res 41: 368–374. doi:10.1203/00006450-199703000-00011.
Burgard P, Bremer HJ, Bührdel P, et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria. Eur J Pediat 158: 46–54. doi:10.1007/s004310051008.
Camfield CS, Joseph M, Hurley T, Campbell K, Sanderson S, Camfield PR (2004) Optimal management of phenylketonuria: a centralized expert team is more successful than a decentralized model of care. J Pediatr 145: 53–57. doi:10.1016/j.jpeds.2004.04.029.
Hanley WB, Feigenbaum A, Clarke JT, Schoonheyt W, Austin V (1993) Vitamin B12 deficiency in adolescents and young adults with phenylketonuria. Lancet 342: 997. doi:10.1016/0140-6736(93)92047-W.
MRC (1993a) Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria. BMJ 306: 115–119.
MRC (1993b) Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria. Arch Dis Child 68: 426–427.
Schweitzer-Krantz S, Burgard P (2000) Survey of national guidelines for the treatment of phenylketonuria. Eur J Pediatr 159(Supplement 2): S70–73.
Van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis 31: 673–679.
Walter JH, White FJ, Hall SK, et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360: 55–57. doi:10.1016/S0140-6736(02)09334-0.
Acknowledgements
The authors thank Professor Dr M. Baumgartner, Dr G. H. J. Boers, Dr A. M. Bosch, Dr L. Cimbalistiene, Professor Dr B. Francois, Professor Dr M. Giovannini, Dr J Jørgensen, Professor Dr P. J. Lee, Dr R. Lugovska, K. Motzfeldt, Rd, E. Muller, Rd, Dr J. B. Nielsen, Dr M Nowacka, Dr M. P. Schwarz, Professor J. H. Walter, and Dr M. Zerjav-Tansek for contributing data. They also thank Mrs C. J. L. Koelink for processing the data and Nutricia for the grant for this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Nenad Blau
Competing interests: None declared
References to electronic databases: Phenylketonuria: OMIM #261600.
Rights and permissions
About this article
Cite this article
van Spronsen, F.J., Ahring, K.K. & Gizewska, M. PKU—What is daily practice in various centres in Europe?. J Inherit Metab Dis 32, 58–64 (2009). https://doi.org/10.1007/s10545-008-0966-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0966-y